Cohance Lifesciences Limited (BOM:543064)
879.35
+9.10 (1.05%)
At close: Aug 29, 2025
Cohance Lifesciences Revenue
Cohance Lifesciences had revenue of 5.49B INR in the quarter ending June 30, 2025, with 138.12% growth. This brings the company's revenue in the last twelve months to 12.59B, up 34.71% year-over-year. In the fiscal year ending March 31, 2025, Cohance Lifesciences had annual revenue of 11.98B with 13.91% growth.
Revenue (ttm)
12.59B
Revenue Growth
+34.71%
P/S Ratio
26.76
Revenue / Employee
10.55M
Employees
1,193
Market Cap
336.89B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2025 | 11.98B | 1.46B | 13.91% |
Mar 31, 2024 | 10.51B | -2.89B | -21.56% |
Mar 31, 2023 | 13.40B | 201.07M | 1.52% |
Mar 31, 2022 | 13.20B | 3.11B | 30.75% |
Mar 31, 2021 | 10.10B | 1.76B | 21.10% |
Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Reliance Industries | 9,765.41B |
HDFC Bank | 2,736.06B |
Tata Consultancy Services | 2,561.48B |
Bharti Airtel | 1,839.41B |
ICICI Bank | 2,054.85B |
State Bank of India | 3,503.84B |
Hindustan Unilever | 639.28B |
Infosys | 1,672.76B |